Intracellular transactivation of the insulin-like growth factor I receptor by an epidermal growth factor receptor

被引:52
作者
Burgaud, JL [1 ]
Baserga, R [1 ]
机构
[1] THOMAS JEFFERSON UNIV,JEFFERSON CANC CTR,PHILADELPHIA,PA 19107
关键词
D O I
10.1006/excr.1996.0096
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Growth factor receptors may be transactivated not only by homologous receptors, but also by heterologous receptors. We have investigated this possibility, using for this purpose R(-)/EGFR cells, which are mouse embryo cells devoid of IGF-I receptors, but overexpressing the EGF receptor, At variance with mouse embryo cells with a wild-type number of IGF-I receptors and overexpressing the EGF receptor, R(-)/EGFR cells cannot grow in EGF only, nor can they form colonies in soft agar. However, if a wild type human IGF-I receptor is stably transfected into R(-)/EGFR cells, growth in EGF and colony formation in soft agar are restored. To determine a possible interaction between the two receptors, we transfected into R(-)/EGFR cells a number of IGF-I receptor mutants with different impaired functions. The only IGF-I receptor that cannot reverse the growth phenotype of R(-)/EGFR cells is a receptor with a point mutation at the ATP-binding site. All other mutant receptors, even when incapable of responding to IGF-I with a mitogenic signal, made R(-)/EGFR cells fully capable of responding with growth to EGF stimulation. IGF-I receptor mutants that are mitogenic but not transforming made R(-)/EGFR cells grow in EGF only, but were incapable of inducing the transformed phenotype. The mutant IGF-I receptors are activated (tyrosyl phosphorylation of IRS-1) in response to EGF, These experiments indicate that certain IGF-I receptor mutants with loss of function can be reactivated intracellularly by an overexpressed EGF receptor and confirm that the C-terminus of the IGF-IR is required for its transforming activity. (C) 1996 Academic Press, Inc.
引用
收藏
页码:412 / 419
页数:8
相关论文
共 62 条
[1]   INTERFERENCE OF THE IGF SYSTEM AS A STRATEGY TO INHIBIT BREAST-CANCER GROWTH [J].
ARTEAGA, CL .
BREAST CANCER RESEARCH AND TREATMENT, 1992, 22 (01) :101-106
[2]  
BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O
[3]   INTERMOLECULAR TRANSPHOSPHORYLATION BETWEEN INSULIN-RECEPTORS AND EGF - INSULIN-RECEPTOR CHIMERAE [J].
BALLOTTI, R ;
LAMMERS, R ;
SCIMECA, JC ;
DULL, T ;
SCHLESSINGER, J ;
ULLRICH, A ;
VANOBBERGHEN, E .
EMBO JOURNAL, 1989, 8 (11) :3303-3309
[4]  
BASERGA R, 1995, CANCER RES, V55, P249
[5]   THE ROLE OF THE IGF-I RECEPTOR IN THE GROWTH AND TRANSFORMATION OF MAMMALIAN-CELLS [J].
BASERGA, R ;
SELL, C ;
PORCU, P ;
RUBINI, M .
CELL PROLIFERATION, 1994, 27 (02) :63-71
[6]  
CHANTRY A, 1995, J BIOL CHEM, V270, P3068
[7]   A 2ND SIGNAL SUPPLIED BY INSULIN-LIKE GROWTH-FACTOR-II IN ONCOGENE-INDUCED TUMORIGENESIS [J].
CHRISTOFORI, G ;
NAIK, P ;
HANAHAN, D .
NATURE, 1994, 369 (6479) :414-418
[9]   VARIABLES CONTROLLING SOMATOMEDIN PRODUCTION BY CULTURED HUMAN-FIBROBLASTS [J].
CLEMMONS, DR ;
SHAW, DS .
JOURNAL OF CELLULAR PHYSIOLOGY, 1983, 115 (02) :137-142
[10]  
CLEMMONS DR, 1981, TISSUE GROWTH FACTOR, P161